{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T13:26:02Z","timestamp":1761744362344},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2016,8,5]],"date-time":"2016-08-05T00:00:00Z","timestamp":1470355200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Gene Ther"],"published-print":{"date-parts":[[2016,9]]},"DOI":"10.1038\/cgt.2016.32","type":"journal-article","created":{"date-parts":[[2016,8,5]],"date-time":"2016-08-05T10:22:14Z","timestamp":1470392534000},"page":"303-314","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Retargeted adenoviruses for radiation-guided gene delivery"],"prefix":"10.1038","volume":"23","author":[{"given":"S A","family":"Kaliberov","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L N","family":"Kaliberova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H","family":"Yan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V","family":"Kapoor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D E","family":"Hallahan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,8,5]]},"reference":[{"key":"BFcgt201632_CR1","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.amsu.2014.04.003","volume":"3","author":"SS Talibi","year":"2014","unstructured":"Talibi SS, Aweid B, Aweid O . Prospective therapies for high-grade glial tumours: a literature review. Ann Med Surg (Lond) 2014; 3: 55\u201359.","journal-title":"Ann Med Surg (Lond)"},{"key":"BFcgt201632_CR2","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1038\/nature07385","volume":"455","author":"Cancer Genome Atlas Research Network","year":"2008","unstructured":"Cancer Genome Atlas Research Network. Comprehensive genomic characterization defines human glioblastoma genes and core pathways. Nature 2008; 455: 1061\u20131068.","journal-title":"Nature"},{"key":"BFcgt201632_CR3","doi-asserted-by":"publisher","first-page":"1396","DOI":"10.1126\/science.1254257","volume":"344","author":"AP Patel","year":"2014","unstructured":"Patel AP, Tirosh I, Trombetta JJ, Shalek AK, Gillespie SM, Wakimoto H et al. Single-cell RNA-seq highlights intratumoral heterogeneity in primary glioblastoma. Science 2014; 344: 1396\u20131401.","journal-title":"Science"},{"key":"BFcgt201632_CR4","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/B978-0-12-398342-8.00007-0","volume":"115","author":"SA Kaliberov","year":"2012","unstructured":"Kaliberov SA, Buchsbaum DJ . Chapter seven\u2014cancer treatment with gene therapy and radiation therapy. Adv Cancer Res 2012; 115: 221\u2013263.","journal-title":"Adv Cancer Res"},{"key":"BFcgt201632_CR5","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1038\/sj.cgt.7700024","volume":"6","author":"WW Zhang","year":"1999","unstructured":"Zhang WW . Development and application of adenoviral vectors for gene therapy of cancer. Cancer Gene Ther 1999; 6: 113\u2013138.","journal-title":"Cancer Gene Ther"},{"key":"BFcgt201632_CR6","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1038\/ng0393-224","volume":"3","author":"S Akli","year":"1993","unstructured":"Akli S, Caillaud C, Vigne E, Stratford-Perricaudet LD, Poenaru L, Perricaudet M et al. Transfer of a foreign gene into the brain using adenovirus vectors. Nat Genet 1993; 3: 224\u2013228.","journal-title":"Nat Genet"},{"key":"BFcgt201632_CR7","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1038\/ng0393-229","volume":"3","author":"G Bajocchi","year":"1993","unstructured":"Bajocchi G, Feldman SH, Crystal RG, Mastrangeli A . Direct in vivo gene transfer to ependymal cells in the central nervous system using recombinant adenovirus vectors. Nat Genet 1993; 3: 229\u2013234.","journal-title":"Nat Genet"},{"key":"BFcgt201632_CR8","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1038\/ng0393-219","volume":"3","author":"BL Davidson","year":"1993","unstructured":"Davidson BL, Allen ED, Kozarsky KF, Wilson JM, Roessler BJ . A model system for in vivo gene transfer into the central nervous system using an adenoviral vector. Nat Genet 1993; 3: 219\u2013223.","journal-title":"Nat Genet"},{"key":"BFcgt201632_CR9","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1038\/sj.cgt.7700086","volume":"7","author":"T Ichikawa","year":"2000","unstructured":"Ichikawa T, Tamiya T, Adachi Y, Ono Y, Matsumoto K, Furuta T et al. In vivo efficacy and toxicity of 5-fluorocytosine\/cytosine deaminase gene therapy for malignant gliomas mediated by adenovirus. Cancer Gene Ther 2000; 7: 74\u201382.","journal-title":"Cancer Gene Ther"},{"key":"BFcgt201632_CR10","first-page":"637","volume":"5","author":"H Li","year":"1999","unstructured":"Li H, Alonso-Vanegas M, Colicos MA, Jung SS, Lochmuller H, Sadikot AF et al. Intracerebral adenovirus-mediated p53 tumor suppressor gene therapy for experimental human glioma. Clin Cancer Res 1999; 5: 637\u2013642.","journal-title":"Clin Cancer Res"},{"key":"BFcgt201632_CR11","doi-asserted-by":"publisher","first-page":"4550","DOI":"10.1158\/0008-5472.CAN-10-0339","volume":"70","author":"RJ Passarella","year":"2010","unstructured":"Passarella RJ, Spratt DE, van der Ende AE, Phillips JG, Wu H, Sathiyakumar V et al. Targeted nanoparticles that deliver a sustained, specific release of Paclitaxel to irradiated tumors. Cancer Res 2010; 70: 4550\u20134559.","journal-title":"Cancer Res"},{"key":"BFcgt201632_CR12","doi-asserted-by":"publisher","first-page":"2299","DOI":"10.1089\/ars.2009.2568","volume":"11","author":"M Gonzalez-Gronow","year":"2009","unstructured":"Gonzalez-Gronow M, Selim MA, Papalas J, Pizzo SV . GRP78: a multifunctional receptor on the cell surface. Antioxid Redox Signal 2009; 11: 2299\u20132306.","journal-title":"Antioxid Redox Signal"},{"key":"BFcgt201632_CR13","doi-asserted-by":"publisher","first-page":"8049","DOI":"10.1074\/jbc.M114.618736","volume":"290","author":"YL Tsai","year":"2015","unstructured":"Tsai YL, Zhang Y, Tseng CC, Stanciauskas R, Pinaud F, Lee AS . Characterization and mechanism of stress-induced translocation of 78-kilodalton glucose-regulated protein (GRP78) to the cell surface. J Biol Chem 2015; 290: 8049\u20138064.","journal-title":"J Biol Chem"},{"key":"BFcgt201632_CR14","doi-asserted-by":"publisher","first-page":"11367","DOI":"10.1128\/JVI.77.21.11367-11377.2003","volume":"77","author":"N Belousova","year":"2003","unstructured":"Belousova N, Korokhov N, Krendelshchikova V, Simonenko V, Mikheeva G, Triozzi PL et al. Genetically targeted adenovirus vector directed to CD40-expressing cells. J Virol 2003; 77: 11367\u201311377.","journal-title":"J Virol"},{"key":"BFcgt201632_CR15","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.virusres.2005.10.002","volume":"116","author":"SC Noureddini","year":"2006","unstructured":"Noureddini SC, Krendelshchikov A, Simonenko V, Hedley SJ, Douglas JT, Curiel DT et al. Generation and selection of targeted adenoviruses embodying optimized vector properties. Virus Res 2006; 116: 185\u2013195.","journal-title":"Virus Res"},{"key":"BFcgt201632_CR16","doi-asserted-by":"publisher","first-page":"2509","DOI":"10.1073\/pnas.95.5.2509","volume":"95","author":"TC He","year":"1998","unstructured":"He TC, Zhou S, da Costa LT, Yu J, Kinzler KW, Vogelstein B . A simplified system for generating recombinant adenoviruses. Proc Natl Acad Sci USA 1998; 95: 2509\u20132514.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFcgt201632_CR17","doi-asserted-by":"crossref","first-page":"7498","DOI":"10.1128\/jvi.70.11.7498-7509.1996","volume":"70","author":"N Mittereder","year":"1996","unstructured":"Mittereder N, March KL, Trapnell BC . Evaluation of the concentration and bioactivity of adenovirus vectors for gene therapy. J Virol 1996; 70: 7498\u20137509.","journal-title":"J Virol"},{"key":"BFcgt201632_CR18","doi-asserted-by":"crossref","first-page":"6839","DOI":"10.1128\/jvi.70.10.6839-6846.1996","volume":"70","author":"VN Krasnykh","year":"1996","unstructured":"Krasnykh VN, Mikheeva GV, Douglas JT, Curiel DT . Generation of recombinant adenovirus vectors with modified fibers for altering viral tropism. J Virol 1996; 70: 6839\u20136846.","journal-title":"J Virol"},{"key":"BFcgt201632_CR19","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1038\/nrclinonc.2014.223","volume":"12","author":"DA Reardon","year":"2015","unstructured":"Reardon DA, Wen PY . Glioma in 2014: unravelling tumour heterogeneity-implications for therapy. Nat Rev Clin Oncol 2015; 12: 69\u201370.","journal-title":"Nat Rev Clin Oncol"},{"key":"BFcgt201632_CR20","doi-asserted-by":"publisher","first-page":"620643","DOI":"10.1155\/2015\/620643","volume":"2015","author":"S Parisi","year":"2015","unstructured":"Parisi S, Corsa P, Raguso A, Perrone A, Cossa S, Munaf\u00f2 T et al. Temozolomide and radiotherapy versus radiotherapy alone in high grade gliomas: a very long term comparative study and literature review. Biomed Res Int 2015; 2015: 620643.","journal-title":"Biomed Res Int"},{"key":"BFcgt201632_CR21","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1586\/14737175.2015.1061934","volume":"15","author":"S Mittal","year":"2015","unstructured":"Mittal S, Pradhan S, Srivastava T . Recent advances in targeted therapy for glioblastoma. Expert Rev Neurother 2015; 15: 935\u2013946.","journal-title":"Expert Rev Neurother"},{"key":"BFcgt201632_CR22","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1016\/S1470-2045(09)70025-7","volume":"10","author":"R Stupp","year":"2009","unstructured":"Stupp R, Hegi ME, Mason WP, van den Bent MJ, Taphoorn MJ, Janzer RC et al. Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial. Lancet Oncol 2009; 10: 459\u2013466.","journal-title":"Lancet Oncol"},{"key":"BFcgt201632_CR23","doi-asserted-by":"publisher","first-page":"1465","DOI":"10.1089\/hum.1996.7.12-1465","volume":"7","author":"SL Eck","year":"1996","unstructured":"Eck SL, Alavi JB, Alavi A, Davis A, Hackney D, Judy K et al. Treatment of advanced CNS malignancies with the recombinant adenovirus H5.010RSVTK: a phase I trial. Hum Gene Ther 1996; 7: 1465\u20131482.","journal-title":"Hum Gene Ther"},{"key":"BFcgt201632_CR24","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1016\/j.gendis.2014.09.009","volume":"1","author":"Ulasov IV","year":"2014","unstructured":"Ulasov IV, Borovjagin AV, Schroede BA, Baryshnikov AY . Oncolytic adenoviruses: a thorny path to glioma cure. Genes Dis 2014; 1: 214\u2013226.","journal-title":"Genes Dis"},{"key":"BFcgt201632_CR25","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1056\/NEJMoa043330","volume":"352","author":"R Stupp","year":"2005","unstructured":"Stupp R, Mason WP, van den Bent MJ, Weller M, Fisher B, Taphoorn MJ et al. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 2005; 352: 987\u2013996.","journal-title":"N Engl J Med"},{"key":"BFcgt201632_CR26","doi-asserted-by":"publisher","first-page":"2080","DOI":"10.18632\/oncotarget.6712","volume":"7","author":"DY Dadey","year":"2016","unstructured":"Dadey DY, Kapoor V, Khudanyan A, Urano F, Kim AH, Thotala D et al. The ATF6 pathway of the ER stress response contributes to enhanced viability in glioblastoma. Oncotarget 2016; 7: 2080\u20132092.","journal-title":"Oncotarget"},{"key":"BFcgt201632_CR27","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.semcancer.2015.04.002","volume":"33","author":"F Tameire","year":"2015","unstructured":"Tameire F, Verginadis II, Koumenis C . Cell intrinsic and extrinsic activators of the unfolded protein response in cancer: mechanisms and targets for therapy. Semin Cancer Biol 2015; 33: 3\u201315.","journal-title":"Semin Cancer Biol"},{"key":"BFcgt201632_CR28","first-page":"289","volume":"71","author":"LM Hendershot","year":"2004","unstructured":"Hendershot LM . The ER function BiP is a master regulator of ER function. Mt Sinai J Med 2004; 71: 289\u2013297.","journal-title":"Mt Sinai J Med"},{"key":"BFcgt201632_CR29","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1016\/j.acthis.2010.11.006","volume":"113","author":"X Xing","year":"2011","unstructured":"Xing X, Li Y, Liu H, Wang L, Sun L . Glucose regulated protein 78 (GRP78) is overexpressed in colorectal carcinoma and regulates colorectal carcinoma cell growth and apoptosis. Acta Histochem 2011; 113: 777\u2013782.","journal-title":"Acta Histochem"},{"key":"BFcgt201632_CR30","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1002\/ijc.27994","volume":"133","author":"MJ Gray","year":"2013","unstructured":"Gray MJ, Mhawech-Fauceglia P, Yoo E, Yang W, Wu E, Lee AS et al. AKT inhibition mitigates GRP78 (glucose-regulated protein) expression and contribution to chemoresistance in endometrial cancers. Int J Cancer 2013; 133: 21\u201330.","journal-title":"Int J Cancer"},{"key":"BFcgt201632_CR31","doi-asserted-by":"publisher","first-page":"10","DOI":"10.3389\/fphar.2013.00010","volume":"4","author":"C Roller","year":"2013","unstructured":"Roller C, Maddalo D . The molecular chaperone GRP78\/BiP in the development of chemoresistance: mechanism and possible treatment. Front Pharmacol 2013; 4: 10.","journal-title":"Front Pharmacol"},{"key":"BFcgt201632_CR32","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/j.ccr.2004.08.018","volume":"6","author":"MA Arap","year":"2004","unstructured":"Arap MA, Lahdenranta J, Mintz PJ, Hajitou A, Sarkis AS, Arap W et al. Cell surface expression of the stress response chaperone GRP78 enables tumor targeting by circulating ligands. Cancer Cell 2004; 6: 275\u2013284.","journal-title":"Cancer Cell"},{"key":"BFcgt201632_CR33","doi-asserted-by":"publisher","first-page":"15065","DOI":"10.1074\/jbc.M109.087445","volume":"285","author":"Y Zhang","year":"2010","unstructured":"Zhang Y, Liu R, Ni M, Gill P, Lee AS . Cell surface relocalization of the endoplasmic reticulum chaperone and unfolded protein response regulator GRP78\/BiP. J Biol Chem 2010; 285: 15065\u201315075.","journal-title":"J Biol Chem"},{"key":"BFcgt201632_CR34","first-page":"33","volume":"11","author":"TA Ajith","year":"2015","unstructured":"Ajith TA . Strategies used in the clinical trials of gene therapy for cancer. J Exp Ther Oncol 2015; 11: 33\u201339.","journal-title":"J Exp Ther Oncol"},{"key":"BFcgt201632_CR35","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/0360-3016(90)90136-8","volume":"19","author":"DE Hallahan","year":"1990","unstructured":"Hallahan DE, Beckett MA, Kufe D, Weichselbaum RR . The interaction between recombinant human tumor necrosis factor and radiation in 13 human tumor cell lines. Int J Radiat Oncol Biol Phys 1990; 19: 69\u201374.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"BFcgt201632_CR36","first-page":"4266","volume":"54","author":"RR Weichselbaum","year":"1994","unstructured":"Weichselbaum RR, Hallahan DE, Beckett MA, Mauceri HJ, Lee H, Sukhatme V et al. Gene therapy targeted by radiation preferentially radiosensitizes tumor cells. Cancer Res 1994; 54: 4266\u20134269.","journal-title":"Cancer Res"},{"key":"BFcgt201632_CR37","doi-asserted-by":"publisher","first-page":"7135","DOI":"10.1038\/sj.onc.1208875","volume":"24","author":"M Hamdi","year":"2005","unstructured":"Hamdi M, Kool J, Cornelissen-Steijger P, Carlotti F, Popeijus HE, van der Burgt C et al. DNA damage in transcribed genes induces apoptosis via the JNK pathway and the JNK-phosphatase MKP-1. Oncogene 2005; 24: 7135\u20137144.","journal-title":"Oncogene"},{"key":"BFcgt201632_CR38","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1038\/sj.onc.1201433","volume":"15","author":"M Martin","year":"1997","unstructured":"Martin M, Vozenin MC, Gault N, Crechet F, Pfarr CM, Lefaix JL . Coactivation of AP-1 activity and TGF-beta1 gene expression in the stress response of normal skin cells to ionizing radiation. Oncogene 1997; 15: 981\u2013989.","journal-title":"Oncogene"},{"key":"BFcgt201632_CR39","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1038\/sj.leu.2401493","volume":"13","author":"WL Blalock","year":"1999","unstructured":"Blalock WL, Weinstein-Oppenheimer C, Chang F, Hoyle PE, Wang XY, Algate PA et al. Signal transduction, cell cycle regulatory, and anti-apoptotic pathways regulated by IL-3 in hematopoietic cells: possible sites for intervention with anti-neoplastic drugs. Leukemia 1999; 13: 1109\u20131166.","journal-title":"Leukemia"},{"key":"BFcgt201632_CR40","doi-asserted-by":"publisher","first-page":"1443","DOI":"10.1080\/09553000050176207","volume":"76","author":"A Beetz","year":"2000","unstructured":"Beetz A, Peter RU, Oppel T, Kaffenberger W, Rupec RA, Meyer M et al. NF-kappaB and AP-1 are responsible for inducibility of the IL-6 promoter by ionizing radiation in HeLa cells. Int J Radiat Biol 2000; 76: 1443\u20131453.","journal-title":"Int J Radiat Biol"},{"key":"BFcgt201632_CR41","doi-asserted-by":"publisher","first-page":"10149","DOI":"10.1073\/pnas.89.21.10149","volume":"89","author":"R Datta","year":"1992","unstructured":"Datta R, Rubin E, Sukhatme V, Qureshi S, Hallahan D, Weichselbaum RR et al. Ionizing radiation activates transcription of the EGR1 gene via CArG elements. Proc Natl Acad Sci USA 1992; 89: 10149\u201310153.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFcgt201632_CR42","first-page":"2723","volume":"23","author":"H Hsu","year":"2003","unstructured":"Hsu H, Rainov NG, Quinones A, Eling DJ, Sakamoto KM, Spear MA . Combined radiation and cytochrome CYP4B1\/4-ipomeanol gene therapy using the EGR1 promoter. Anticancer Res 2003; 23: 2723\u20132728.","journal-title":"Anticancer Res"},{"key":"BFcgt201632_CR43","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/sj.cgt.7700879","volume":"13","author":"JJ Mezhir","year":"2006","unstructured":"Mezhir JJ, Smith KD, Posner MC, Senzer N, Yamini B, Kufe DW et al. Ionizing radiation: a genetic switch for cancer therapy. Cancer Gene Ther 2006; 13: 1\u20136.","journal-title":"Cancer Gene Ther"},{"key":"BFcgt201632_CR44","doi-asserted-by":"publisher","first-page":"S68","DOI":"10.2307\/3578765","volume":"138","author":"DA Boothman","year":"1994","unstructured":"Boothman DA, Lee IW, Sahijdak WM . Isolation of an X-ray-responsive element in the promoter region of tissue-type plasminogen activator: potential uses of X-ray-responsive elements for gene therapy. Radiat Res 1994; 138: S68\u2013S71.","journal-title":"Radiat Res"},{"key":"BFcgt201632_CR45","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1038\/sj.gt.3302871","volume":"14","author":"HO McCarthy","year":"2007","unstructured":"McCarthy HO, Worthington J, Barrett E, Cosimo E, Boyd M, Mairs RJ et al. p21((WAF1))-mediated transcriptional targeting of inducible nitric oxide synthase gene therapy sensitizes tumours to fractionated radiotherapy. Gene Ther 2007; 14: 246\u2013255.","journal-title":"Gene Ther"},{"key":"BFcgt201632_CR46","first-page":"1187","volume":"61","author":"S Takahashi","year":"2001","unstructured":"Takahashi S, Saito S, Ohtani N, Sakai T . Involvement of the Oct-1 regulatory element of the gadd45 promoter in the p53-independent response to ultraviolet irradiation. Cancer Res 2001; 61: 1187\u20131195.","journal-title":"Cancer Res"},{"key":"BFcgt201632_CR47","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1269\/jrr.44.311","volume":"44","author":"K Daino","year":"2003","unstructured":"Daino K, Ichimura S, Nenoi M . Comprehensive search for X-ray-responsive elements and binding factors in the regulatory region of the GADD45a gene. J Radiat Res 2003; 44: 311\u2013318.","journal-title":"J Radiat Res"},{"key":"BFcgt201632_CR48","doi-asserted-by":"publisher","first-page":"453","DOI":"10.4155\/tde.14.123","volume":"6","author":"DA Spencer","year":"2015","unstructured":"Spencer DA, Young JS, Kanojia D, Kim JW, Polster SP, Murphy JP et al. Unlocking the promise of oncolytic virotherapy in glioma: combination with chemotherapy to enhance efficacy. Ther Deliv 2015; 6: 453\u2013468.","journal-title":"Ther Deliv"},{"key":"BFcgt201632_CR49","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1016\/S1470-2045(13)70274-2","volume":"14","author":"M Westphal","year":"2013","unstructured":"Westphal M, Yl\u00e4-Herttuala S, Martin J, Warnke P, Menei P, Eckland D et al. Adenovirus-mediated gene therapy with sitimagene ceradenovec followed by intravenous ganciclovir for patients with operable high-grade glioma (ASPECT): a randomised, open-label, phase 3 trial. Lancet Oncol 2013; 14: 823\u2013833.","journal-title":"Lancet Oncol"},{"key":"BFcgt201632_CR50","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1016\/j.radonc.2011.05.078","volume":"99","author":"Y Touchefeu","year":"2011","unstructured":"Touchefeu Y, Vassaux G, Harrington KJ . Oncolytic viruses in radiation oncology. Radiother Oncol 2011; 99: 262\u2013270.","journal-title":"Radiother Oncol"}],"container-title":["Cancer Gene Therapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/cgt201632.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/cgt201632","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/cgt201632.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T13:14:11Z","timestamp":1684415651000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/cgt201632"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,8,5]]},"references-count":50,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2016,9]]}},"alternative-id":["BFcgt201632"],"URL":"https:\/\/doi.org\/10.1038\/cgt.2016.32","relation":{},"ISSN":["0929-1903","1476-5500"],"issn-type":[{"value":"0929-1903","type":"print"},{"value":"1476-5500","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,8,5]]},"assertion":[{"value":"2 March 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 June 2016","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 June 2016","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 August 2016","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}